s6y
Company name or ticker
Search
IOVANCE BIOTHERAPEUTICS, INC.
424B5
Prospectus filed pursuant to Rule 424(b)(5)
Filed
Thursday, September 21, 2017
Accession number
0001571049-17-007995
Documents
FINAL PROSPECTUS SUPPLEMENT
424B5
On sec.gov
Filing index
All files
Complete submission text
SGML header